IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 785
NA - Nord America 717
EU - Europa 321
SA - Sud America 190
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.060
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 682
SG - Singapore 265
VN - Vietnam 165
CN - Cina 140
BR - Brasile 128
IT - Italia 115
HK - Hong Kong 53
BD - Bangladesh 50
DE - Germania 44
FR - Francia 42
AR - Argentina 23
AT - Austria 23
CA - Canada 15
FI - Finlandia 14
IQ - Iraq 14
UA - Ucraina 14
GB - Regno Unito 13
IN - India 13
KR - Corea 13
MX - Messico 12
CO - Colombia 10
PK - Pakistan 9
SN - Senegal 9
RU - Federazione Russa 8
ZA - Sudafrica 8
DZ - Algeria 7
SE - Svezia 7
TR - Turchia 7
CL - Cile 6
EC - Ecuador 6
ES - Italia 6
PY - Paraguay 6
ID - Indonesia 5
NL - Olanda 5
PL - Polonia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
EG - Egitto 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BG - Bulgaria 3
JP - Giappone 3
KG - Kirghizistan 3
MA - Marocco 3
NP - Nepal 3
TH - Thailandia 3
TN - Tunisia 3
AU - Australia 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SC - Seychelles 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PF - Polinesia Francese 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.060
Salva come PNG Salva come JPEG
Città #
Dallas 223
Singapore 128
San Jose 72
Ashburn 54
Hong Kong 52
Ho Chi Minh City 50
Council Bluffs 48
Hanoi 47
Beijing 37
Chandler 35
New York 25
Lauterbourg 23
Los Angeles 18
Boardman 14
Helsinki 14
Vienna 14
Seoul 13
Da Nang 11
Florence 11
Rende 11
Munich 10
Dakar 9
Hefei 9
Santa Clara 9
Shanghai 9
São Paulo 9
Guangzhou 7
Haiphong 7
Montreal 7
San Mateo 7
Baghdad 6
Buenos Aires 6
Frankfurt am Main 6
Biên Hòa 5
Jacksonville 5
Medellín 5
Mexico City 5
Naples 5
Rio de Janeiro 5
Rome 5
São José do Rio Preto 5
Tashkent 5
Bremen 4
Brescia 4
Buffalo 4
Duhok 4
Elk Grove Village 4
Falkenstein 4
Goiânia 4
Lawrence 4
Phoenix 4
Riyadh 4
Secaucus 4
Warsaw 4
Acerra 3
Bari 3
Brussels 3
Caracas 3
Catania 3
Charlotte 3
Curitiba 3
Dearborn 3
Fortaleza 3
Genoa 3
Islamabad 3
Izmir 3
Mauá 3
Milan 3
Mosul 3
Noida 3
Ogden 3
Orem 3
Recife 3
Redwood City 3
Roxbury 3
Salvador 3
Tianjin 3
Uberlândia 3
Wuhan 3
Abu Dhabi 2
Amman 2
Amsterdam 2
Asunción 2
Aversa 2
Baku 2
Bandar Seri Begawan 2
Bishkek 2
Borgomanero 2
Boston 2
Brooklyn 2
Cairo 2
Cape Town 2
Casablanca 2
Chennai 2
Chicago 2
Cochabamba 2
Cosenza 2
Dhaka 2
Edison 2
Formosa 2
Totale 1.211
Salva come PNG Salva come JPEG
Nome #
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? 176
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 150
First evidence on the novel hypothalamic peptide Phoenixin-14 as cardiac modulator and cardioprotective in normal and obese rats 142
Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction 135
Vaccination in Multiple Myeloma: Challenges and Strategies 132
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma 120
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 111
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 110
Epigenetic regulation of mitochondrial quality control genes in multiple myeloma: A sequenom massarray pilot investigation on hmcls 107
Rilzabrutinib for the Treatment of Immune Thrombocytopenia 80
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 79
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma 77
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients 69
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent versus combination drugs 68
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions 62
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents 51
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 41
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization 35
Real‐World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia 33
The Non-Coding RNA Journal Club: Highlights on Recent Papers-14 29
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy 28
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 27
Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies 25
Chemotherapy‐Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune‐Based Approaches 24
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 22
Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy 20
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies 18
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 17
Targeting the Menin– KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation 15
Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis 15
Comparative efficacy of different therapeutic approaches in treatment naïve FLT3-mutated AML eligible for intensive chemotherapy: a Bayesian network meta-analysis of randomized trials 15
Reshaping multiple myeloma treatment: recent breakthroughs 14
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 14
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 13
Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions 13
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 12
Targeting Ikaros and Aiolos: Next‐Generation Cereblon E3 Ligase Modulators in MM 11
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives 7
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies 4
First‐Line Treatment of IGHV ‐Unmutated Chronic Lymphocytic Leukemia: A Network Meta‐Analysis of Targeted and Chemoimmunotherapy Regimens 2
From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management 2
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohort 1
To Treat or Not to Treat: Navigating Early‐Stage CLL in the Era of Targeted Therapy 1
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities 1
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational Opportunities 1
Totale 2.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202246 0 3 1 5 2 1 1 14 1 2 5 11
2022/202391 10 12 3 12 14 5 2 10 14 1 5 3
2023/202494 11 5 8 10 2 17 9 1 5 5 10 11
2024/2025184 11 15 5 11 3 5 5 7 26 24 12 60
2025/20261.679 64 114 227 120 207 134 127 92 168 218 130 78
Totale 2.129